CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1/2 Study of TAS-120 in Patients With Advanced Solid Tumors Harboring FGF/FGFR Aberrations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02052778
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:42.035167+00:00
Published At: 2024-03-20T00:00:00+00:00
Record Updated At: 2025-03-27
Results Posted At: 2024-03-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cholangiocarcinoma", "Urothelial Cancer", "Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors", "Primary CNS Tumors", "Breast Cancer", "Gastric Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-27"
protocolSection.identificationModule.nctId: "NCT02052778"
protocolSection.identificationModule.officialTitle: "Phase 1/2 Study of TAS-120 in Patients With Advanced Solid Tumors Harboring FGF/FGFR Aberrations"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-03-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.